Agenda for Day 2 - Tuesday, June 2, 2026Tuesday, 2 June 2026

Specialty pharmacies are playing an increasingly central role in the delivery of complex therapies, but their evolution is raising important legal, regulatory, and strategic questions across Canada. Unpack how shifting regulations, recent legal developments in Quebec, and growing expectations around patient choice are redefining access, distribution, and care models, and what it means for the future of patient-centric care.

• Examine the evolving role of specialty pharmacies and their impact on access and care delivery.

• Understand recent legal and regulatory developments in Quebec and their broader industry implications.

• Evaluate how competition, informed patient choice, and evolving expectations are reshaping distribution strategies and patient-centric models.

An inside look at the creation and launch of a complex patient support program built to ensure equitable access, streamline a highly intricate care pathway, and deliver exceptional patient and provider experiences.

• Strategies for designing support programs that truly center patient needs while remaining intuitive for customers and easy to navigate.
• Approaches to overcoming systemic and logistical challenges to ensure timely, equitable access to care.
• Lessons learned from integrating insights across patients, providers, payers, field teams, and internal partners to refine and elevate program impact.

Rare disease patients face unique barriers. Understand how PSPs can be tailored to deliver personalized care, improve access, and foster collaboration among stakeholders to support this underserved population.

• Identify the distinct challenges rare disease patients encounter.

• Customize PSPs to meet specialized needs and improve outcomes.

• Collaborate effectively to deliver comprehensive support for rare disease patients.

Patient Support Programs are becoming more complex and costly, creating increasing pressure on pharmaceutical companies to improve visibility, governance, and financial sustainability. Technology, analytics, and emerging AI capabilities are beginning to support a shift from reactive program management to more proactive, data-driven oversight. This session explores how the PSP operations are evolving and how digital tools and analytics can improve transparency, performance measurement, and operational decision-making across the PSP ecosystem.

• Understand how the PSP operating model is evolving and where technology and analytics can support stronger program oversight and sustainability.
• Explore how AI and digital tools can assist with operational workflows, exception management, documentation review, and insight generation across PSP activities.
• Examine how integrated data platforms and performance dashboards can improve transparency, financial oversight, and strategic decision-making.
• Discuss practical examples of how technology can strengthen PSP governance, support audit readiness, and reduce operational complexity.

Data is revolutionizing PSPs. See how real-world evidence (RWE) informs program design, measures impact, and improves patient outcomes through actionable insights and case studies.

• Use RWE to optimize PSP strategies and performance.

• Apply analytics-driven methods to measure program effectiveness.

• Review success stories showcasing RWE integration in Canadian PSPs.

Close out the conference with an engaging, fast‑paced discussion led by a senior patient support programs leader. This interactive session will focus on key challenges shaping PSPs in Canada today, including patient access and the evolving regulatory landscape. Bring your questions and engage directly for practical insights and forward‑looking perspectives as the event concludes.